Revolution Medicine-2026-JPM.pdf

1、 2026 Revolution Medicines,Inc.On Target to Outsmart Cancer44th Annual JP Morgan Healthcare ConferenceJanuary 12,20262Legal DisclaimerThis presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act.All statements other than statements of histo

2、rical facts contained in this presentation,including statements regarding our future results of operations and financial position,business strategy,prospective products,availability of funding,ability to manage existing collaborations and establish new strategic collaborations,licensing or other arr

3、angements,the scope,progress,results and costs of developing our product candidates or any other future product candidates,conducting clinical trials,the potential market size and size of the potential patient populations for our product candidates,the timing and likelihood of success of obtaining p

4、roduct approvals,plans and objectives of management for future operations,the scope of protection we are able to establish and maintain for intellectual property rights covering our product candidates,future results of anticipated products and the impact of global events and other macroeconomic cond

5、itions on our business are forward-looking statements.These statements involve known and unknown risks,uncertainties and other important factors that may cause our actual results,performance or achievements to be materially different from any future results,performance or achievements expressed or i

6、mplied by the forward-looking statements.Because forward-looking statements are inherently subject to risks and uncertainties,some of which cannot be predicted or quantified and some of which are beyond our control,you should not rely on these forward-looking statements as predictions of future even